<img src="https://ws.zoominfo.com/pixel/eCRg8hzy2qp0kNUl6E1g" width="1" height="1" style="display: none;">

Lung Cancer Diagnostic Testing & Biopharma Services

slide-1 (1) (1)-1
GettyImages-1314569482 (1) (1)-1

Testing solutions Spanning the Lung Cancer Continuum of Care

Access fast, reliable, and actionable biological insights with our genomic and proteomic tests to gain a deeper understanding of each patient’s disease state, help expedite diagnosis, and guide confident treatment decisions.

tabs-nodify-lung-hero (1)-1


Nodify Lung® testing consists of two blood-based proteomic tests, the Nodify CDT® and Nodify XL2® tests, designed to help providers quickly and confidently decipher the risk of malignancy of a lung nodule.

tabs-iqlung-hero (1) (1)-1


IQLung Treatment Guidance testing consists of the GeneStrat® targeted test, the GeneStrat NGS™ genomic test and the VeriStrat® proteomic test for a broader view of each patient's disease state, with results in 3 business days.* IQLung testing empowers care teams with a testing strategy for any stage of non-small cell lung cancer (NSCLC) and delivers timely biological insights to help expedite personalized treatment decisions.

Biopharma Services

Capitalize on our scientific rigor and established track record of successful partnerships to meet all your research needs and expedite the diagnostic development process from biomarker discovery to commercialization.

home-services-1 (1)-1

Biomarker Discovery & Development

Our breadth of biomarker discovery and assay development services helps our partners to better identify the right patient for the right therapy.

home-services-2 (1)-1

Clinical Trial Support & Testing

Navigate the clinical trial process for therapeutics with proven solutions, including sample management, data analytics, and quality and regulatory services.

iStock-1341507387-crop (1)-1

Companion Diagnostic Partnering

Our companion diagnostic development services arm biopharma partners with solutions to help overcome the challenges and risks associated identifying the right patient for the right therapy in clinical development and in the commercial arena.

NEWSROOM Our Newsroom

Your go-to source for company announcements, news, events, and media.

Press Icon

Press Releases

Explore Biodesix's latest news releases, achievements and updates.

Blog Icon

Biodesix Blog

Read educational articles and insights from our experts.

Calendar Icon

Events Calendar

Connect with Team Biodesix at upcoming industry events and conferences.

Media Icon

Media Kit

Explore our Media Kit

Our Purpose

Powering personalized care for all

We deliver diagnostic insights in some of the most challenging disease states, such as lung cancer, by leveraging our broad scientific expertise and purpose-driven approach, so all patients can benefit from timely, personalized information to improve their care.

GettyImages-1314569482 (1) (1)-1

Data-driven diagnostic solutions

We are here for you

Our in-house Customer Care experts are only a click away

Our data library

Explore our library of publications, abstracts, videos, and more

*3 business days represents the average turnaround time for testing, individual test turnaround times may vary.